Industry News 19 Oct 2026

EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD

Source: The Manila Times •By globenewswire •1 min read

- LUCIA did not achieve the primary endpoint of statistical non-inferiority in mean change in BCVA versus on-label aflibercept control, despite demonstrating visual improvement- - Key secondary endpoints in LUCIA were met including a superior 38% reduction in treatment burden (nominal p-value - - Continued favorable safety profile for DURAVYU with redosing - ─ DME program remains on track with pivotal Phase 3 topline data from two identical clinical trials anticipated in Q4 2027 - - Conference call to discuss the results to be held today at 8:00 a.m. EDT - WATERTOWN, Mass., Oct. 19, 2026 (GLOB

This is a short summary. The full story is published by The Manila Times.

Read full story at The Manila Times
#clinical trial#phase 3#tmt newswire

Related news

Industry News
U.S. FDA Approves Subcutaneous Induction Regimen for AbbVie's SKYRIZI® for Adults With Moderately to Severely Active…

Now with a new route of induction administration, subcutaneous SKYRIZI supports early symptomatic and endoscopic control with an on-body injector…

Investing News Network (inn)• 23 Oct 2026 •1 min read
#abbv#fda approves#nyse-abbv
Read story
Regulatory
AMA and EMA issue joint guidance on Ebola vaccine development

EMA’s Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely start of…

EMA• 23 Oct 2026 •1 min read
#clinical trial#vaccine
Read story
Industry News
Chronic Spontaneous Urticaria Clinical Trials Update 2026: Phase-Wise Pipeline Status, Drug Profiles, and Key…
Abnewswire• 23 Oct 2026
#clinical trial
Read story
Industry News
New clinical trial backed by Andy Burnham could speed up Alzheimer’s treatments

The Prime Minister’s father Roy died with Alzheimer’s disease in September.

The Irish News• 22 Oct 2026 •1 min read
#ad-smart#alzheimer's disease#alzheimer's research uk
Read story
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Trending tags
#pharma #pharmaceutical #fda approval #diseases #pharmaceuticals #clinical trial #fda approves #pharma and healthcare #biosimilar #phase iii #science and innovations #research #vaccine #drug #world news
Browse by category
Industry News 89 Regulatory 5
Top sources
A Abnewswire 10 stories
I Indianpharmapost 5 stories
F Finanznachrichten.de 5 stories
K Kalkine Media 4 stories
F FDA 4 stories
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit